More Syntara Limited news Syntara LimitedASX: SNT Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor Oct 11, 2018 at 1:48 AM UTC · Issued by Syntara Limited As issuedPlain English Syntara Limited has released a press release. View Attachment
